Our team has been working hard to finalize details for The MedTech Conference in San Jose, and we are excited to announce that our interactive conference agenda is live.
The MedTech Conference is fast approaching, with less than three months until we gather in San Jose for the largest annual gathering of medical technology professionals in North America. We’re well into planning the event, and our Program Preview is now available for download!
Each year, our goal is to develop an A+ lineup of conference programming that is cutting-edge, informative and impactful. In the past, we’ve featured a number of panel tracks based on industry sector. This year, we’ve revised our approach, and each session at The MedTech Conference will fall under one (or more) of our four program pillars:
Today we are happy to announce that The MedTech Conference will partner with the Medical Device Manufacturers Association (MDMA) to make AdvaMed's annual conference an even more rewarding experience going forward.
MDMA is comprised of nearly 300 member companies that represent the innovative and entrepreneurial sector of the medical technology industry. MDMA's mission is to promote the public health and improve patient care through the advocacy of innovative, research-driven medical device technology.
In our final panel session of the day, Health Connections: Digitizing Consumers and Patients, we explored how technology innovation and convergence - wearables, in vivo diagnostics, mobile, and more - are driving a data revolution and delivering virtual care.
Following the lunch keynote session, we explored how new data streams, sophisticated analytics, and cutting-edge cognitive computing are enhancing and assisting decision-making in today’s digital health landscape during The Future of Health is Cognitive panel session.
During lunch, not only did attendees get to eat, but they also got to take part in our lunch keynote discussion: Evidation Health - A Startup Case Study in Innovation.
Following a conversation that touched heavily upon the need for better FDA regulation for digital health technologies was our regulatory panel session: Regulating at the Speed of Innovation - FDA Pre-Check for Software Development.
Our first panel session of the day, Disruption and Opportunity: The Future of Health Care is Now, explored how key challenges and trends in health care delivery are creating market opportunities for digital technologies and applications.
After throwing back a couple cups of coffee and some delicious pastries, our day started off with a powerful keynote address from Jessica Mega, MD, MPH, Chief Medical Officer at Verily Life Sciences (the health care arm of Google/Alphabet).